As a result, compounds which chelate iron can be efficient inhibitors of IDO1 activity (135–140) and IDO1 inhibitors have been developed for their iron complexation properties (136–138, 141–148) and their resulting anti-cancer activity  (126, 149). The gene discussed is IDO1; the disease is cancer.